AVITA Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
AVITA Medical, Inc. filed a Current Report on Form 8-K dated April 9, 2021, with the report signed on April 12, 2021. The filing reports a corporate governance event under Item 8.01, “Other Events.”
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Change
Effective April 9, 2021, the Board appointed Jeremy Curnock Cook as an independent director and member of the Audit Committee. The Board determined that he satisfied applicable Audit Committee requirements under the Securities Exchange Act.
Following the appointment, the disclosed committee composition was:
- Lou Panaccio: independent; Compensation Committee member.
- Jeremy Curnock Cook: independent; Compensation Committee member, Audit Committee member, and Nomination Committee member.
- Louis Drapeau: independent; Compensation Committee member, Audit Committee chair, and Nomination Committee member.
- Professor Suzanne Crow: independent; Compensation Committee chair and Nomination Committee chair.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance, operating outlook, risk-factor updates, contingencies, or unusual financial items. It identifies Jeremy Curnock Cook’s appointment to the Audit Committee as the principal reported event.
Investor Verification Items
- Verify the effective date and qualifications of Jeremy Curnock Cook’s appointment.
- Confirm the committee memberships and chair positions disclosed in the filing.
- Review subsequent filings for any later changes to Board composition or committee assignments.